Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, David Cameron, Binghe Xu et al.|New England Journal of Medicine|2022Cited by 2.5k
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLCByoung Chul Cho, Patricia Lorenzini, Shun Lu et al.|New England Journal of Medicine|2024Cited by 369
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancerByoung Chul Cho, Alexander I. Spira, Enriqueta Felip et al.|Future Oncology|2021Cited by 93
Prognostic value of preoperative hematological markers combined with molecular pathology in patients with diffuse gliomasWeiwei Wang, Yunbo Zhan, Fengjiang Zhang et al.|Aging|2019Cited by 27
ALG13 participates in epileptogenesis via regulation of GABAA receptors in mouse modelsJunming Huo, Tao Sun|Cell Death Discovery|2020Cited by 23